Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011161
Filing Date
2021-08-10
Accepted
2021-08-10 17:01:13
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q azyo-20210630x10q.htm   iXBRL 10-Q 1752644
2 EX-31.1 azyo-20210630xex31d1.htm EX-31.1 14652
3 EX-31.2 azyo-20210630xex31d2.htm EX-31.2 14653
4 EX-32.1 azyo-20210630xex32d1.htm EX-32.1 6761
5 EX-32.2 azyo-20210630xex32d2.htm EX-32.2 6721
  Complete submission text file 0001558370-21-011161.txt   6239280

Data Files

Seq Description Document Type Size
6 EX-101.SCH azyo-20210630.xsd EX-101.SCH 42757
7 EX-101.CAL azyo-20210630_cal.xml EX-101.CAL 40131
8 EX-101.DEF azyo-20210630_def.xml EX-101.DEF 185126
9 EX-101.LAB azyo-20210630_lab.xml EX-101.LAB 409072
10 EX-101.PRE azyo-20210630_pre.xml EX-101.PRE 316149
11 EXTRACTED XBRL INSTANCE DOCUMENT azyo-20210630x10q_htm.xml XML 915728
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 211160883
SIC: 2836 Biological Products, (No Diagnostic Substances)